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Abstract
Background: Iran has a widespread diagnostics and clinical support services (DCSS) network that plays 
a crucial role in providing diagnostic and clinical support services to both inpatient and outpatient care. 
However, very little is known on the application of quality assurance (QA) policies in DCSS units. This study 
explores the extent of application of eleven QA strategies in DCSS units within Iranian hospitals and its 
association with hospital characteristics.
Methods: A descriptive cross-sectional study was conducted in 2009/2010. Data were collected from 554 
DCSS units among 84 hospitals. 
Results: The average reported application rate for the QA strategies ranged from 57%-94% in the DCSS 
units. Most frequently reported were checking drugs expiration dates (94%), pharmacopoeia availability 
(92%), equipment calibration (87%) and identifying responsibilities (86%). Least reported was external 
auditing of the DCSS (57%). The clinical chemistry and microbiology laboratories (84%), pharmacies, blood 
bank services (83%) reported highest average application rates across all questioned QA strategies. Lowest 
application rates were reported in human tissue banks (50%). There was no significant difference between 
the reported application rates in DCSS in the general/specialized, teaching/research, nonteaching/research 
hospitals with the exception of pharmacies and radiology departments. They reported availability of a written 
QA plan significantly more often in research hospitals. Nearly all QA strategies were reported to be applied 
significantly more often in the DCSS of Social Security Organization (SSO) and private-for-profit hospitals 
than in governmental hospitals. 
Conclusion: There is still room for strengthening the managerial cycle of QA systems and accountability 
in the DCSS in Iranian hospitals. Getting feedback, change and learning through application of specific QA 
strategies (eg, external/internal audits) can be improved. Both the effectiveness of QA strategies in practice, 
and the application of these strategies in outpatient DCSS units require further policy attention. 
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Implications for policy makers
• More attention at policy level is needed for the application of quality assurance (QA) strategies in both inpatient and outpatient diagnostics and 
clinical support services (DCSS) units across different organizational affiliations to increase the compliance with national QA requirements.
• There is room for strengthening the managerial cycle of QA systems in DCSS units by moving from formalization and standardization 
towards feedback and improvement of QA strategies.  
• More reliable statistics in medical and diagnostic errors are needed to better evaluate, and improve the effectiveness of current QA strategies 
in DCSS units.
Implications for public
The general public should be able to trust that the diagnostics tests and clinical support services they receive are appropriate, accurate and of high-
quality. On the other hand, the government should be able to guarantee a minimum level of quality of diagnostic and clinical support services for 
the public in all diagnostics and clinical support services (DCSS) units both in outpatient and inpatient units and regardless their organizational 
affiliations.  
Key Messages 
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Background
Accurate diagnostic tests and high-quality appropriate clinical 
support services are essential in the diagnostic process and 
treatment of patients.1 Currently, the provision of most clinical 
services in hospitals is directly linked to their diagnostics and 
clinical support services (DCSS). Almost all patients receive 
services by the DCSS during their hospitalization.2 Failure 
to provide these services with a sufficient quality level can 
result in unjustified treatment, which may harm patients.3-8 
Although it is difficult to find out the exact statistics of the 
diagnostic and medical errors, lethal diagnostic errors have 
been estimated through the Global Trigger Tool to affect 
40 000-80 000 people per year in the United States.9 
Given the critical role of DCSS, there has recently been an 
increased awareness among patients, policy-makers and 
healthcare managers about the need for quality assurance 
(QA) in DCSS.1,10 QA in DCSS comprises a series of 
critical activities that can influence the appropriateness 
(ie, clinical effectiveness) of services to patients and their 
health and clinical outcomes. Examples of strategies to 
ensure the quality of care in DCSS units include quality 
control, improving accuracy of the diagnostics, external 
and internal quality assessment and audit, identifying 
responsibilities, standardization through guidelines and 
standards, monitoring of key processes and equipment 
calibration.10,11 
Despite the increased focus on ensuring quality in the DCSS 
particularly in developed countries, clinical care in some 
(often middle- and low-income) countries is lacking QA and 
regulatory controls.1,12 Iran is such a country of which very 
little is known on the application of QA strategies in DCSS 
units. 
Iran has a widespread DCSS network that plays a crucial 
role in providing diagnostic and clinical support services to 
both inpatient and outpatient care. The network consists of 
more than 4000 public and private clinical laboratories and 
thousands of diagnostic radiology units and pharmacies.13,14 
However, there are limited numbers of specialized DCSS units 
(eg, human tissue bank or nuclear medicine). Based on the 
Iranian National Health Act (1955), all hospitals are obliged 
to have a laboratory, diagnostic radiology and pharmacy in 
place. According to this Act, all DCSS units both inside and 
outside of hospitals should obey a set of standards and be 
licensed to practice.15,16 The government together with the 
relevant specialty associations (eg, radiologist association) 
controls the quality of services in these units.17 The health 
reference laboratory (HRL) and general directorate of 
laboratory affairs (GDLA) in each medical sciences university 
control the quality of diagnostic tests, check compliance with 
safety guidelines and standards for all clinical laboratories. 
The Iranian Blood Transfusion Organization (IBTO) provides 
guidelines and standards for blood banks and transfusion 
services across the country.18 
More recently, there has been an increasing interest 
among DCSS units to get International Organization for 
Standardization (ISO) certification, in particular among 
private DCSS. To obtain this, the DCSS units have to 
comply with the basic requirements for acceptable levels of 
quality and performance, undergo planned and unplanned 
inspections. Furthermore, the DCSS that are located in 
hospitals should undergo a governmental evaluation program 
at least once a year.19
Despite the regulatory importance given to the quality in 
DCSS units, to date very few studies have explored the 
actual application of QA strategies in DCSS units in practice. 
The majority of the existing studies have focused only on 
the quality control and accuracy of diagnostic (especially 
laboratory) tests.20,21 Insight in the application of  QA strategies 
can provide a view on the strategies that can guarantee and 
ensure the quality of DCSS services. This study therefore 
aims to describe the extent of application of QA strategies 
for ensuring the quality of services provided by DCSS units, 
and explore how the level of application is associated with 
the characteristics of hospitals in which the DCSS units are 
located, in particular the teaching/research and ownership 
status and the hospital performance grade. 
Methods
This is a descriptive cross-sectional study conducted from 
October 2009 through February 2010 among 554 DCSS 
units of 84 hospitals in Iran. Data were collected through a 
questionnaire that consisted of 11 close-ended questions 
covering main QA strategies related to the DCSS units. The 
explored strategies were: (i) the identification and (formal) 
division of responsibilities, (ii) the presence of a written QA 
plan, (iii) the presence of written guidelines and standards for 
the main tests or treatment, (iv) monitoring of key processes 
and actions, (v) systematic evaluation of collected data, (vi) 
inspection, calibration and maintenance of equipment on a 
regular basis, and (vii/viii) periodic internal/external audit of 
the service. The strategies are categorized in 4 main groups 
representing the managerial cycle for QA; (1) Identification 
and documentation of responsibilities, (2) Availability of 
a QA plan, guidelines and standards, (3) Monitoring and 
systematic evaluation of services, and (4) Inspection and 
audit of services. In case of pharmacy units, we also explored 
three specific additional QA strategies including checking 
drugs and medical disposals’ expiration date, compliance 
with the national pharmacopoeia, and presence and use of a 
computerized prescription system (CPS). The questionnaire 
was distributed among the responsible persons for QA 
activities at the DCSS units, including head of department, 
general supervisor, leader/manager or technical supervisor.
The Questionnaire
The questions included in the questionnaire were derived 
from the Methods of Assessing Response to Quality 
Improvement Strategies (MARQuIS) project’s questionnaire, 
which was developed to assess the application of different 
quality strategies in hospitals in European Union (EU) 
countries.22,23 This was a validated questionnaire which was 
implemented across Europe, and could be used to compare 
the results of our study. The questions were first translated 
from English to Farsi and adapted for Iranian hospitals by 
the authors. After verifying the content of the translated and 
adapted questionnaire, it was piloted in 5 hospitals (including 
3 public governmental, 1 private-for-profit and 1 Social 
Security Organization [SSO] hospital). Necessary changes 
and further improvements were made based on the responses 
received from the pilot hospitals. Each respondent received a 
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separate questionnaire including questions on the hospital’s 
characteristics, and 11 questions related to the available QA 
strategies for DCSS at each hospital. The questionnaire was 
self-administered, and sent out to the responsible persons 
for QA activities at the DCSS units and returned by mail. 
Respondents were contacted to address any issues observed. 
Study Population
The questionnaire was distributed in 130 (out of 850) 
general and specialized hospitals across Iran, which were 
selected based on purposive sampling. We aimed to have a 
representative sample of all types of hospitals in our study 
selecting 130 hospitals based on the hospitals willingness 
and eligibility for our study. Participation in the survey 
was voluntary. We received 98 questionnaires from the 
hospitals (response rate of 75%). The received questionnaires 
were assessed for completeness and consistency. Fourteen 
questionnaires were excluded from the final analysis due 
to incompleteness or inconsistency, resulting in a final 
population of 84 hospitals. 
The study population comprised mainly university 
governmental and SSO hospitals, which all achieved an 
acceptable grade provided by the government as part of the 
annual hospital performance grading system. This system 
consists of a 6 level grading scale from the best performer 
‘excellent 1’, ‘1’, ‘2’, ‘3’, ‘4 or substandard’ to worst performer 
‘5 or to be shut down.’19 Four hospitals included in our 
study obtained the highest grade, and only 1 hospital the 
lowest acceptable grade (‘3’). A subgroup of participating 
hospitals was also involved in teaching activities besides 
their therapeutic activities. A small minority of hospitals was 
conducting research besides their therapeutic and teaching 
activities (Table 1). 
Results
The Diagnostic and Clinical Support Services in Iranian 
Hospitals
More than 96% of hospitals reported to have a clinical 
chemistry laboratory (n = 81), diagnostic radiology (n = 82), 
and pharmacy services (n = 84) in place. In contrast, only 4 
(5%) hospitals reported having human tissue bank service. 
Other services that were not very frequently reported to 
be available were radiotherapy (12%), magnetic resonance 
imaging (MRI) (13%), cardiac catheterization (18%) and 
nuclear medicine (19%).
The Extent of Application of Quality Assurance Strategies
Table 2 summarizes the results of the extent of reported 
application of QA strategies in the DCSS units of hospitals. 
The results show that almost all QA strategies were reported 
to be used by the majority of hospitals, though some more 
than others. Most frequently reported strategies were having 
a procedure for checking the expiration dates of drugs 
(94%) and pharmacopoeia (92%) in pharmacies, equipment 
calibration (87%), and identification of responsibilities (86%). 
The least reported strategy was external audit of the services 
(average: 57%).
In addition, the following figures illustrate the extent of 
application of each QA strategies in different DCSS units 
(Figure).
The Association Between the Application of Quality 
Assurance in the Diagnostic and Clinical Support Services 
Units and Hospital Characteristics 
There is no significant difference between the reported 
application rate of QA strategies in DCSS in general and 
specialized hospitals, with the exception of pharmacies. The 
pharmacies in the general hospitals reported having a written 
QA plan significantly more often available than specialized 
hospitals (on average 70% compared to 33.3%, P = .014).
Hospital’s ownership type was a relevant feature for the 
application of QA strategies by pharmacies, radiology units, 
laboratories (clinical chemistry, microbiology and pathology), 
MRI, and blood bank units. These units reported applying QA 
strategies in the SSO’s hospitals significantly more often than 
the units in the university hospitals. This was also the case for 
the vast majority of QA strategies in the private-for-profit and 
nonprofit hospitals where they reported the application of 
QA strategies more often than university hospitals. The only 
exception was the identification of responsibilities, which did 
not differ by ownership type, as shown in Table 3.
There was no significant difference in the reported application 
rate of QA strategies in the DCSS units in the therapeutic 
hospitals and the hospitals that were involved in teaching 
and research activities alongside their therapeutic activities. 
The only exception was the significantly higher reported 
Table 1. Characteristics of the Study Population
The Number of Hospitals Included by Their Ownership, Type, Annual Evaluation Grade and Teaching Status, n (%)
Ownership,
n (%)
Type,
 n (%)
Annual Evaluation Grade, n (%) Teaching Status, n (%)
Excellent 1 1 2 3 Therapeutic Therapeutic + 
Teaching 
Therapeutic + Teaching 
+ Research
University-
governmental
46 (55)
General, 35 (76) - 30 (91) 2 (6) 1 (3) 9 (26) 23 (66) 3 (8)
Specialty or subspecialty, 11 (24) - 11 (100) - - - 8 (73) 3 (27)
SSO, 21 (25) General, 21 (100) 3 (14) 17 (81) 1 (5) - 12 (57) 9 (43) -
Specialty or subspecialty - - - - - - -
Private-for-
profit, 12 (14)
General, 11 (92) 1 (10) 8 (80) 1 (10) - 11 (100) - -
Specialty or subspecialty, 1 (8) - 1 (100) - - - - -
Private 
nonprofit, 5 (6)
General, 5 (100) - 4 (80) 1 (20) - 3 (60) 1 (20) 1 (20)
Specialty or subspecialty - - - - - - -
Abbreviation: SSO, Social Security Organization.
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Figure. The Extent of Application of QA Strategies in the Participating DCSS Units. Abbreviations: CC, clinical chemistry laboratory; MB, microbiology labo-
ratory; PA, pathology laboratory; RD, radiology; RT, radiotherapy; MRI, magnetic resonance imaging; CTS, computerized tomography scan; NM, nuclear 
medicine; CZ, cardiac catheterization; PH, pharmacy; HU, human tissue bank; BB, blood bank; DCSS, diagnostics and clinical support services; QA, quality 
assurance.
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availability of a written QA plan in the radiology departments 
in the hospitals which were involved in research activities 
besides their therapeutic and teaching activities (P = .036). 
The availability of a written QA plan in the therapeutic, 
therapeutic/teaching, and therapeutic/teaching/research 
hospitals were reported by 75.8%, 56.4% and 100% of the 
hospitals, respectively.
The radiology, MRI, computerized tomography (CT) scan, 
nuclear medicine and radiotherapy departments in the 
hospitals with different annual performance evaluation grades 
were significantly different in the reported identification of 
responsibilities, availability of a written QA plan, monitoring 
of key processes and systematic evaluation of collected data 
strategies as shown in Table 4.
The identification of responsibilities (except in the radiology 
departments), availability of a written QA plan, monitoring 
of key processes and systematic evaluation of collected 
data in the radiology, MRI, CT scan, nuclear medicine and 
radiotherapy departments were significantly more often 
reported in the grade 1 hospitals compared to the excellent 
1 hospitals. 
There is no significant difference between the reported 
application rate of having pharmacopoeia and a CPS available, 
and checking drugs expiration dates in the pharmacies in 
different (general/specialized and teaching/nonteaching) 
hospitals.
Discussion
We studied the extent of application of 4 groups of QA 
strategies (representing the managerial cycle) by inpatient 
DCSS units and its association with the key characteristics of 
Iranian hospitals. To our best knowledge, this is the first study 
that explores the application of specific QA strategies in the 
DCSS units in Iranian hospitals. However, the study has some 
limitations concerning the sample size and composition of the 
study population. First of all, the study is limited to the DCSS 
units that are located within Iranian hospitals excluding DCSS 
in outpatient units. Because of time and financial limitations 
we were not able to expand our study sample to the DCSS 
units outside of hospitals. Moreover, the DCSS units outside 
of hospitals are mostly part of the private sector in Iran. As 
a result, they are not statutorily obliged to participate in 
research. Secondly, the study population included a relatively 
small number of specialized DCSS units such as human tissue 
bank or radiotherapy departments compared to the total 
number of DCSS units in Iran, which is a reflection of the 
relatively small number of available specialized DCSS units 
across the country. Nevertheless, we belief our study provides 
a good indication of the current state of affairs concerning 
the use of QA strategies by DCSS units in hospitals. Finally, 
the use of a purposive sampling method and a self-reported 
questionnaire in this study might have led to some biases in 
the results. For instance, respondents may be more likely to 
report a better performance in application of QA strategies. To 
minimize the possible biases because of purposive sampling, 
we checked all data on any inconsistencies and uncertainties. 
We conducted follow up conversations with respondents for 
any identified uncertain and unclear data and excluded data 
which were unlikely based on our experiences. 
Our study revealed that all strategies were reported to be 
widely used (ranging 57%-94%) by the DCSS. Most frequently 
reported strategies were checking the expiration date of drugs 
Table 3. The Associations Between the Extent of Application of QA Strategies in DCSS units and Ownership of Hospitals
QA  Strategies Category QA  Strategies Subgroups DCSS Unit
The Application Rate of Strategy by 
the Ownership of Hospitals (%) P 
University SSO PFP PNP
A) Identification of 
responsibilities
Responsibilities identified and laid 
down on paper?
B) Availability of  QA plan, 
guidelines and standards
Availability of written QA plan?   
Pharmacy 53.3 95.0 58.3 60 .013
Radiology 53.5 95.2 80.0 60 .007
Availability of written procedures, 
guidelines and standards?
Pharmacy 66.7 100 100 60 .003
C) Monitoring and systematic 
evaluation of service
Monitoring of key processes in this 
service?
Clinical chemistry laboratory 75.5 100 100 100 .020
Microbiology laboratory 78.6 100 100 100 .037
Pharmacy 62.2 95.0 100 80 .005
Systematic evaluation of collected 
data?
Pathology laboratory 47.1 75.0 77.8 100 .045
Pharmacy 51.1 95.0 75.0 20 .001
D) Inspection and audit of 
service
Inspection, calibration and 
maintenance of equipment?  
Clinical chemistry laboratory 87.8 100 100 60 .027
Radiology 90.7 100 90.0 60 .045
MRI 100 100 100 0 .029
Periodic internal audit of service?  
Pathology laboratory 38.2 75.0 100 80 .002
Microbiology laboratory 61.9 84.2 100 100 .018
Pharmacy 60.0 95.0 75.0 60 .035
Radiology 65.1 95.2 90.0 60 .032
Periodic external audit of service?   
Clinical chemistry laboratory 53.7 100 72.7 40 .002
Microbiology laboratory 54.8 100 72.7 40 .003
Blood bank 48.7 89.5 80.0 50 .013
Pharmacy 31.1 90.0 50.0 0 .000
Radiology 37.2 95.2 50.0 20 .000
Abbreviations: DCSS, diagnostics and clinical support services; QA, quality assurance; MRI, magnetic resonance imaging; SSO, Social Security Organization; PFP, 
private-for-profit; PNP, private nonprofit.
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and having a pharmacopoeia, equipment calibration, and 
identification/outline of responsibilities. Particularly QA 
strategies that are directly linked to the safety of patients in 
DCSS units, were reported to be highly applied. The least 
reported strategy was the performance of external audits of 
the services by an accreditation or certification institute. The 
results also showed that there was no significant association 
between the reported application rates of QA strategies in 
DCSS (with the exception of the availability of a written QA 
plan) and the hospital type and teaching status of hospitals. 
The reported application rates of all QA strategies (with 
the exception of identification of responsibilities) in the 
clinical chemistry, microbiology and pathology laboratories, 
pharmacy, radiology, MRI and blood bank departments 
appear to be associated with the ownership type of hospitals, 
which was reported significantly higher in the SSO’s hospitals 
compared to the other hospitals. It seems the implementation 
of total quality management (TQM) systems based on ISO 
standards was the main factor in successful application 
of QA strategies in the DCSS units at the SSO hospitals.19 
Moreover, the application of identification of responsibilities, 
availability of written QA plan, monitoring of key processes 
and systematic evaluation of collected data strategies in the 
radiology, MRI, CT scan, nuclear medicine and radiotherapy 
departments were associated to the annual performance 
evaluation grade of the hospitals. These findings were to a 
great extent also confirmed by other studies in this field.24
From Formalization and Standardization of Quality Assurance 
Strategies Toward Feedback and Improvement 
Although the majority of the QA strategies examined in this 
study were reported to be widely applied by DCSS units, 
emphasis seems to be on formalization and standardization 
rather than on feedback and improvement. The first steps of 
the management cycle (formalization and standardization) 
are reported to be covered but reports on actual closing the 
loop through feedback and change and hence institutionalized 
continuous quality control and improvement seem less 
common. This is also confirmed by other studies in Iranian 
hospitals.21,25 Particularly the application of QA strategies 
such as external and internal audits in most DCSS units, or 
CPS in the pharmacies seem in need of strengthening towards 
further completing the managerial cycle for QA in hospitals. 
Audit is one of the main strategies to monitor and improve 
the quality of the DCSS units.11,26 Furthermore, audits are 
necessary to identify the main concerns of the clinical 
performance of DCSS services for patients, receive feedback, 
change and learning.27 Despite having a potential critical role 
in improving quality of clinical care, the application of audits 
is not being reported sufficiently in some DCSS units (such 
as radiology, radiotherapy, laboratory, pharmacy and blood 
bank) particularly in the university and nonprofit hospitals. 
In general, it seems there are some potential barriers in the 
execution of audits not only in DCSS units, but across the 
hospital sector in Iran. It might be as consequence of the 
execution of the annual performance evaluation in the DCSS 
units in Iranian hospitals. This might cause misunderstanding 
that the internal audits of the DCSS services at specific units 
are not necessary. Another barrier might be the reluctance of 
the hospitals and relevant departments to be controlled for 
quality initiatives. 
Regarding the application of QA strategies in pharmacies, 
nearly all pharmacies reported to have a pharmacopoeia, 
and a procedure for checking the expiration dates of drugs 
before providing them to patients. However, the application 
of some of the QA strategies (eg, CPS) should be improved 
in pharmacies. The impact of these strategies in QA in 
pharmacies has also been reported by other studies in this 
field.15 Our study shows that only around three-fourths of 
pharmacies have a CPS in place. Although this may appear 
sufficiently high, there are still many reported adverse events 
in Iran due to medication errors that can be prevented using 
CPS.28 The effective application of the CPS as one of the 
main QA strategies in pharmacies might help decrease the 
Table 4. The Associations Between the Extent of Application of QA Strategies in DCSS Units and Hospital Annual Evaluation Grade
QA Strategies Category QA Strategies Subgroups DCSS Unit
The extent of application rate of strategy by 
the grade of hospitals P 
Excellent 1 
(Best)
Grade 1 Grade 2
Grade 3 
(Worst)
Identification of 
responsibilities
Responsibilities identified and laid down 
on paper?
Radiology 100 89.9 50 - .041
MRI 0 89.9 - - .035
CT scan 50 96.3 0 - .039
Availability of QA plan, 
guidelines and standards
Availability of written QA plan?   
MRI 0 87.5 - - .047
Nuclear medicine 0 90.0 - - .026
Radiology 0 100 - - .025
Availability of written procedures, 
guidelines and standards?
- - - - - -
Monitoring and systematic 
evaluation of service
Monitoring of key processes in this 
service?
MRI 0 100 - - .003
Nuclear medicine 0 90.0 - - .026
Radiotherapy 0 100 - - .025
Systematic evaluation of collected data? Nuclear medicine 0 90.0 - - .026
Inspection and audit of 
service
Inspection, calibration and maintenance 
of equipment?  
- - - - - -
Periodic internal audit of service?  - - - - - -
Periodic external audit of service?   - - - - - -
Abbreviations: DCSS, diagnostics and clinical support services; QA, quality assurance; MRI, magnetic resonance imaging; CT, computerized tomography.
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medication errors.
Improving the Effectiveness of Quality Assurance Strategies 
in the Diagnostic and Clinical Support Services Units
Despite the relatively high average application rates reported 
for the majority of the QA strategies in the DCSS units (as 
shown in Table 2), the statistics in medical and diagnostic 
errors cause concern for healthcare policy-makers as they 
may point to potential hazardous diagnostic and clinical 
support services in Iranian hospitals. Although there are no 
reliable statistics available on this matter in DCSS units, it 
has been reported that a large number of people experience 
adverse events every year due to medication and diagnostic 
errors, substandard treatments and poor clinical support 
services in Iran.28 An estimated 24 500 people die each year 
due to medical and diagnostic errors in Iran. In addition, the 
prevalence of hospital acquired infections is reported as high 
as 8%-10% of admitted patients in Iranian hospitals.24 This 
is a global health problem as many healthcare systems are 
still faced with medical and diagnostic errors. Nevertheless, 
these problems partly would be manageable by improving 
the effectiveness in medical and clinical services using 
effective strategies through QA approaches and increase the 
accountability of hospitals including DCSS units. This leaves 
the debate open for the real impact of the application of QA 
strategies in the DCSS units in practice. It seems there is still 
a remarkable difference between the reported application rate 
of QA strategies in DCSS units and their impact on quality 
of care. It might be because the QA strategies are not being 
applied sufficiently effective in the DCSS units. Improvement 
of the organizational responsiveness and internal use of 
quality outcomes for quality improvement purposes, feedback 
systems and sharing the results, quality improvement, 
learning and creation of a quality culture in the DCSS units 
may increase the effectiveness of strategies and complete 
the managerial cycle of QA in these units.24,25 This will likely 
improve the internal and external accountability of hospitals 
and consequently the DCSS units. 
 
A Balance in Applying Quality Assurance Strategies in the 
Diagnostic and Clinical Support Services Both in Inpatient 
and Outpatient Units 
Our study showed that the QA strategies are widely reported 
in the DCSS units located inside hospitals, probably partly 
because of the existence of QA monitoring systems which 
are applied to all inpatient units within hospitals. According 
to the healthcare regulations in Iran, the diagnostic and 
clinical support services that are located within hospitals 
should undergo particular scheduled and routine programs 
assisting QA compliance.19 Therefore, the compliance with 
the application of some QA strategies (eg, written guidelines 
and standards) are checked in the annual performance 
evaluation process which is also obligatory for the DCSS 
units located within the hospitals and may increase the level 
of compliances by these units located. Although we did not 
study the application status in outpatient units, it is known 
that they are not obliged to apply QA strategies except for 
clinical laboratories (need to implement national quality 
standards adapted from ISO 15 189 standards since few years 
ago).14,29 This underscores the need for close attention to 
the application of the strategies in outpatient DCSS units to 
increase the compliance with national QA requirements. 
Conclusion
Although QA strategies seem to be adequately applied in 
most inpatient DCSS units of Iranian hospitals, getting 
feedback, implementing changes and learning need to 
be improved to complete the managerial cycle of the QA 
system. Given the high reported percentage of application 
of QA strategies, the DCSS in Iranian hospitals demonstrate 
at least a keen awareness of quality issues. However, there 
are concerns about the relatively low application of some 
specific strategies including the audits in some DCSS units 
and CPS in pharmacies. Execution of the audit programs in 
DCSS units may help these units to really improve their level 
of quality. This can be achieved by statutorily incorporation 
of audit programs in the hospital performance evaluation 
program and using the results for internal hospital quality 
improvement processes in hospitals including DCSS units. 
Moreover, the effectiveness of QA strategies in practice in 
inpatient DCSS units needs to be improved, given the gap 
in the reported QA application rates, adverse events and 
complications. The magnitude of the reported problems in 
hospitals ask for action to further increase the effectiveness 
QA strategies and their use for both internal accountability 
(quality improvement actions) of DCSS units in addition to 
external accountability purposes. It is also recommended to 
pay more attention to QA strategies in outpatient DCSS units, 
given the current policy attention of the Iranian government 
on inpatient settings.
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